Harvard scientists design evolutionary traps to stop viral mutations

Beyond infectious disease, the authors see wider uses for this framework. In cancer immunotherapy, treatments such as CAR‑T cell therapy arms immune cells with engineered, antibody‑like receptors to target tumors that themselves evolve.

Source:

Harvard University

Journal reference: